Dave Juurlink

Head
Division of Clinical Pharmacology and Toxicology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada, Canada

Poster(s):

• (288) Risk of SARS-CoV-2 Infection Following Initial COVID-19 Vaccination by Location
  Sunday, August 28, 2022

  8:00 AM – 1:45 PM CEST